Lupin, China's SUP ink pact for COPD drug Tiotropium DPI
Under the partnership that will enable Lupin to expand footprint in China, SUP will obtain regulatory approvals for selling Tiotropium DPI in China. Lupin will be the marketing authorisation holder and responsible for manufacturing of the product.
Tiotropium DPI is known for its efficacy in improving lung function and quality of life for patients suffering from respiratory conditions. Their partnership comes in backdrop of increasing prevalence of respiratory conditions, Lupin said in a release on Monday.
'This partnership demonstrates our commitment to developing critical products for the treatment of respiratory diseases such as COPD and establishing our leadership in the global respiratory health sector,' Lupin's President of Corporate Development Fabrice Egros said.
SUP president Wang Li said 'by bringing more efficient and superior products to market, we aim to make significant breakthroughs in respiratory disease treatment in China, allowing more patients to benefit from international high-quality and innovative products and enjoy respiratory health.'
Lupin shares closed with a gain of less than 1% on the BSE at ₹2,010.55 each on Monday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
a few seconds ago
- Business Standard
IndusInd Bank Q1 profit drops 72% to ₹604 crore; NII falls to ₹4,640 crore
Private sector lender Indusind Bank on Monday reported a 72 per cent drop in its consolidated net profit for the June quarter at Rs 604 crore. Indusind Bank, which is reeling under a slew of issues stemming from alleged irregularities of the management in recognising bad loans and trading reverses, had reported a net profit of Rs 2,171 crore in the year-ago period. It had reported a loss of Rs 2,329 crore in the preceding March quarter, and the interim management, which has taken over operations of the business after the resignation of leadership including then chief executive Sumant Kathpalia, had said that all the possible impacts are recognised. Total income dropped to Rs 14,420.80 crore in the April-June quarter of FY26 compared to Rs 14,988.38 crore in the year-ago period. The lender's core net interest income also declined to Rs 4,640 crore during the reporting quarter against Rs 5,408 crore. Decline in fee and other income was relatively limited, with the overall number dropping to Rs 2,157 crore from Rs 2,442 crore in the year-ago period. The gross non-performing assets ratio for the lender increased to 3.64 per cent in June against 3.13 per cent in March, but the provisions declined on-quarter to Rs 1,760 crore from Rs 2,522 crore. IndusInd Bank Chairman Sunil Mehta said the bank has delivered "clean and profitable" results in the June quarter, marking a "robust recovery" from the March quarter. "The Committee of Executives has ensured seamless continuity and effective execution during this phase. The Bank has taken decisive action on legacy issues, strengthened governance, and enhanced operational controls," he said. The overall capital adequacy of the lender stood at 16.63 per cent as of June 30, and included a core buffer of 15.48 per cent. Indusind Bank shares closed 2.62 per cent down at Rs 802.15 on BSE ahead of the results announcement, as against a 0.70 per cent correction on the benchmark Sensex.
Hans India
a few seconds ago
- Hans India
NSDL IPO Opens on July 30: Price, GMP, Lot Size, Subscription Details
The Initial Public Offering (IPO) of National Securities Depository Ltd. (NSDL) will open for subscription on Wednesday, July 30. NSDL is a SEBI-registered Market Infrastructure Institution (MII), and it will be listed on the BSE. GMP (Grey Market Premium) Today – July 28 As of 5 p.m. on July 28, the grey market premium (GMP) for the NSDL IPO was ₹137 per share, according to Investorgain. This suggests that NSDL shares might list at around ₹937 per share, which is 17.12% higher than the IPO's top price of ₹800. ⚠️ Note: GMP is unofficial and based on market guesswork. Important Details of NSDL IPO Total Issue Size: ₹4,011.60 crore (Offer for Sale only – 5.01 crore shares). Price Band: ₹760 to ₹800 per share. Lot Size: 18 shares per lot. Minimum Investment (Retail): ₹13,680 (1 lot). sNII Minimum Investment: ₹2,01,600 (14 lots). bNII Minimum Investment: ₹10,08,000 (70 lots). IPO Dates
Hans India
a few seconds ago
- Hans India
Bangladesh plane crash: 33 individuals, including 27 children, still hospitalised
As many as 33 people, including 27 children, still remain hospitalised following last week's tragic plane crash into Dhaka's Milestone School and college, local media reported on Monday. Professor Nasir Uddin, the acting Director of the Sheikh Hasina National Institute of Burn and Plastic Surgery in Dhaka, confirmed that of those injured, three people are in a very 'critical' condition. "The good news is that three patients with intermediate-level injuries are now stable enough to be sent home. However, considering the weather and at the request of their families, they will be discharged after their next dressing," Bangladesh's leading daily, the Dhaka Tribune, quoted Nasir Uddin as saying during a media briefing on Monday. "As of yesterday (Sunday), two patients were on a ventilator, and we lost one of them. Currently, 33 individuals are admitted. Among them, three are in critical condition, and another three are classified as severe. A total of 27 are children," he added while declining to give out any other information, including confirmation of the total death toll resulting from the crash. "The Ministry will disclose the official number of fatalities," he said. On July 26, local media reported that the death toll from this tragic incident had climbed up to 34. Among the 34 people who died in the tragic jet crash, the majority are children. According to the Inter-Services Public Relations (ISPR), the media division of the South Asia nation's Armed Forces, the Bangladesh Air Force's Chinese-made F-7 BGI training aircraft took off at 1:06 p.m. (local time) on July 21 and crashed into the Milestone School and College building in Dhaka's Uttara around 1.30 p.m. A medical team from India is also currently visiting Bangladesh to provide medical support to the country's authorities for treatment of critically injured patients in the aftermath of the plane crash. The team has reviewed each of the critical cases, exchanging views on the treatment methodologies, and conveyed their assessment on the future course of treatment. The team includes doctors and nurses from Delhi's Ram Manohar Lohia Hospital and Safdarjung Hospital -- two of India's leading centres for burn treatment and plastic surgery.
